{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:46:09Z","timestamp":1783107969033,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.det.2010.03.015","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:01:09Z","timestamp":1275026469000},"page":"525-534","source":"Crossref","is-referenced-by-count":17,"title":["Innovative Use of Topical Metronidazole"],"prefix":"10.1016","volume":"28","author":[{"given":"Catherine M.","family":"Zip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2340\/0001555561182183","article-title":"Metronidazole and demodex folliculorum","volume":"61","author":"Persi","year":"1981","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF01646108","article-title":"Impact of topical metronidazole on the skin and colon microflora in patients with rosacea","volume":"15","author":"Eriksson","year":"1987","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib3","first-page":"94","article-title":"Topical metronidazole: a new therapy for rosacea","volume":"9","author":"Schmadel","year":"1990","journal-title":"Clin Pharm"},{"issue":"8","key":"10.1016\/j.det.2010.03.015_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1211\/jpp.59.8.0010","article-title":"Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system","volume":"59","author":"Narayanan","year":"2007","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2133.1983.tb03972.x","article-title":"Treatment of rosacea with 1% metronidazole cream. A double-blind study","volume":"108","author":"Neilsen","year":"1983","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/106002808702100410","article-title":"Evaluation of topical metronidazole gel in acne rosacea","volume":"21","author":"Aronson","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.123.5.609","article-title":"Topical metronidazole therapy for rosacea","volume":"123","author":"Bleicher","year":"1987","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib8","first-page":"44","article-title":"A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea","volume":"61","author":"Breneman","year":"1998","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib9","first-page":"23","article-title":"Topical therapies for rosacea","volume":"5","author":"Nally","year":"2006","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.015_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0536.2006.01064.x","article-title":"Allergic contact dermatitis to topical metronidazole-3 cases","volume":"56","author":"Madsen","year":"2007","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib11","first-page":"269","article-title":"Gel vehicles are not inherently more irritating than creams","volume":"5","author":"Kirkland","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"4 Suppl","key":"10.1016\/j.det.2010.03.015_bib12","first-page":"18","article-title":"A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HAS-3)","volume":"77","author":"Dow","year":"2006","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib13","first-page":"317","article-title":"Metronidazole in the treatment of rosacea: do formulation, dosing and concentration matter?","volume":"5","author":"Yoo","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials","volume":"36","author":"Lamp","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0190-9622(98)70337-8","article-title":"The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial","volume":"39","author":"Jorizzo","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2010.03.015_bib16","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.det.2010.03.015_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl","key":"10.1016\/j.det.2010.03.015_bib18","first-page":"3","article-title":"Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea","volume":"77","author":"Wolf","year":"2006","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib19","first-page":"317","article-title":"Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%","volume":"79","author":"Colon","year":"2007","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.det.2010.03.015_bib20","first-page":"357","article-title":"Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib22","first-page":"473","article-title":"Topical metronidazole combination therapy in the clinical management of rosacea","volume":"4","author":"Del Rosso","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.det.2010.03.015_bib23","first-page":"664","article-title":"Anti-inflammatory dose doxycycline in the treatment of rosacea","volume":"8","author":"Del Rosso","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.1983.tb04003.x","article-title":"The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream [letter]","volume":"109","author":"Nielsen","year":"1983","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.015_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib26","first-page":"120","article-title":"Results of a national rosacea patient survey: common issues that concern rosacea suffers","volume":"8","author":"Elewski","year":"2009","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000051582","article-title":"Topical metronidazole in seborrheic dermatitis-a double-blind study","volume":"202","author":"Parsad","year":"2001","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.det.2010.03.015_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-4362.2003.01981.x","article-title":"Is topical metronidazole effective in seborrheic dermatitis? A double-blind study","volume":"42","author":"Koca","year":"2003","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/0378-6323.26745","article-title":"The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: a double-blind study","volume":"72","author":"Siadat","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib30","first-page":"313","article-title":"Is metronidazole 0.75% gel effective in the treatment of seborrheic dermatitis? A double-blind, placebo controlled study","volume":"17","author":"Ozcan","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1468-3083.2006.01927.x","article-title":"Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study","volume":"21","author":"Seckin","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546630802687349","article-title":"Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrheic dermatitis: a randomized clinical study","volume":"20","author":"Cicek","year":"2009","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1085-5629(99)80018-2","article-title":"Perioral dermatitis in children","volume":"18","author":"Laude","year":"1999","journal-title":"Semin Cutan Med Surg"},{"issue":"5 Pt 1","key":"10.1016\/j.det.2010.03.015_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0190-9622(92)70238-B","article-title":"Perioral dermatitis in childhood","volume":"27","author":"Manders","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"5 Pt 2","key":"10.1016\/j.det.2010.03.015_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0190-9622(94)70243-8","article-title":"Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children","volume":"31","author":"Miller","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000245950","article-title":"Perioral dermatitis in children-clinical presentation, pathogenesis-related factors and response to topical metronidazole","volume":"195","author":"Boeck","year":"1997","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2006.05.031","article-title":"Periorificial dermatitis in children and adolescents","volume":"55","author":"Nguyen","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2010.03.015_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0190-9622(91)70038-4","article-title":"Topical metronidazole in the treatment of perioral dermatitis","volume":"24","author":"Veien","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000084754","article-title":"Critical appraisal of reports on the treatment of perioral dermatitis","volume":"210","author":"Weber","year":"2005","journal-title":"Dermatology"},{"issue":"18 Suppl","key":"10.1016\/j.det.2010.03.015_bib40","first-page":"1S","article-title":"Targeting the epidermal growth factor receptor for cancer therapy","volume":"20","author":"Mendelsohn","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1523-1747.ep12259731","article-title":"Visualization of epidermal growth factor receptors in human epidermis","volume":"82","author":"Nanney","year":"1984","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib42","first-page":"236","article-title":"The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGRF inhibitors","volume":"4","author":"Lacouture","year":"2006","journal-title":"J Support Oncol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11523-009-0114-0","article-title":"Skin toxicities associated with epidermal growth factor receptor inhibitors","volume":"4","author":"Li","year":"2009","journal-title":"Target Oncol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib44","first-page":"186","article-title":"Toward evidence-based management of the dermatologic effects of EGRF inhibitors","volume":"23","author":"Lorusso","year":"2009","journal-title":"Oncology"},{"issue":"3-4","key":"10.1016\/j.det.2010.03.015_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000112795","article-title":"Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results","volume":"72","author":"Boone","year":"2007","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1634\/theoncologist.12-5-610","article-title":"Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management","volume":"12","author":"Lynch","year":"2007","journal-title":"Oncologist"},{"issue":"18S","key":"10.1016\/j.det.2010.03.015_bib47","first-page":"494s","article-title":"Does tetracycline prevent\/palliate epidermal growth factor receptor (EGRF) inhibitor-induced rash? A phase III trial from the North Central Cancer Treatment Group (N03CB) (abstract LBA9006)","volume":"25","author":"Jatoi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.det.2010.03.015_bib48","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","article-title":"Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption","volume":"25","author":"Scope","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2005.10.010","article-title":"Dermatologic side effects associated with the epidermal growth factor receptor inhibitors","volume":"55","author":"Agero","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2009.03.046","article-title":"A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption","volume":"61","author":"Scope","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"11 Suppl 5","key":"10.1016\/j.det.2010.03.015_bib51","first-page":"22","article-title":"Clinical management of EGRFI dermatologic toxicities: the European perspective","volume":"21","author":"Segaert","year":"2007","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.det.2010.03.015_bib52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ejca.2006.11.016","article-title":"Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors","volume":"43","author":"Galimont-Collen","year":"2007","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0732-8893(86)90089-1","article-title":"Quantitative microbiology of pressure sores in different stages of healing","volume":"5","author":"Sapico","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8057","key":"10.1016\/j.det.2010.03.015_bib54","first-page":"213","article-title":"Treatment of anaerobically infected pressure sores with topical metronidazole","volume":"1","author":"Jones","year":"1978","journal-title":"Lancet"},{"issue":"4-5","key":"10.1016\/j.det.2010.03.015_bib55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0959-8049(92)90142-O","article-title":"A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours","volume":"28A","author":"Bower","year":"1992","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.det.2010.03.015_bib56","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/bjon.2004.13.Sup2.13233","article-title":"A topical metronidazole gel used to treat malodorous wounds","volume":"13","author":"Bale","year":"2004","journal-title":"Br J Nurs"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib57","first-page":"18","article-title":"Topical metronidazole for the treatment of wound odor: a review of the literature","volume":"54","author":"Paul","year":"2008","journal-title":"Ostomy Wound Manage"},{"issue":"8","key":"10.1016\/j.det.2010.03.015_bib58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1346-8138.1996.tb02646.x","article-title":"Drug related involvement of specific sites in fixed eruptions: a statistical evaluation","volume":"23","author":"Sharma","year":"1996","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1034\/j.1600-0536.2001.440107-3.x","article-title":"Fixed-drug eruption due to metronidazole with positive topical provocation","volume":"44","author":"Gastaminza","year":"2001","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.det.2010.03.015_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2230.2002.01067.x","article-title":"Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis","volume":"27","author":"Short","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.015_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1600-0536.2002.460219.x","article-title":"Fixed drug eruption caused by metronidazole","volume":"46","author":"Vila","year":"2002","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.det.2010.03.015_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archderm.135.1.93","article-title":"Acute generalized exanthematous pustulosis induced by metronidazole: the role of patch testing","volume":"135","author":"Watsky","year":"1999","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.015_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.dad.0000160982.75176.6c","article-title":"Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis","volume":"27","author":"Girardi","year":"2005","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.det.2010.03.015_bib64","first-page":"274","article-title":"Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing","volume":"197","author":"Jan","year":"1998","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.det.2010.03.015_bib65","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI12118","article-title":"T-cell involvement in drug-induced acute generalized exanthematous pustulosis","volume":"107","author":"Britschgi","year":"2001","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.det.2010.03.015_bib66","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.139.9.1181","article-title":"A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis","volume":"139","author":"Mashiah","year":"2003","journal-title":"Arch Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T09:36:17Z","timestamp":1685612177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0733863510000562"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.03.015","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}